Sonoma Pharmaceuticals Receives Three New United Arab Emirates Regulatory Approvals: Acuicyn® for Management of Blepharitis, Microsafe® Oral Care for Mucositis and Sinudox® for Chronic Si...
Sonoma Pharmaceuticals, Inc. (SNOA)
Last sonoma pharmaceuticals, inc. earnings: 2/14 05:13 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.sonomapharma.com
Company Research
Source: GlobeNewswire
PETALUMA, Calif., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, warrants SNOAW), a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced tissue care, today announced it has received three new regulatory approvals from the United Arab Emirates Ministry of Health & Prevention. The first approval is for Acuicyn® eyelid and eyelash hygiene, an antimicrobial solution (hypochlorous acid) indicated to treat symptoms and causes of blepharitis on the eyelid and eyelash. Acuicyn kills microorganisms which can cause irritation, infection and ocular surface disease. The second approval is for Microsafe® Oral Care, an antiseptic mouth and throat rinse (hypochlorous acid) that eliminates harmful bacteria, viruses and fungi. It relieves symptoms of pain and inflammation caused by mucositis while accelerating the healing process of wounds and ulcerations in the oral ca
Show less
Read more
Impact Snapshot
Event Time:
SNOA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNOA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNOA alerts
High impacting Sonoma Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
SNOA
News
- Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States [Yahoo! Finance]Yahoo! Finance
- Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United StatesAccesswire
- Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections [Yahoo! Finance]Yahoo! Finance
- Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections Accesswire
- Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences [Yahoo! Finance]Yahoo! Finance
SNOA
Sec Filings
- 4/9/24 - Form 8-K
- 4/2/24 - Form 8-K
- 3/22/24 - Form 8-K
- SNOA's page on the SEC website